Literature DB >> 27297094

Differential Contributions of Ubiquitin-Modified APOBEC3G Lysine Residues to HIV-1 Vif-Induced Degradation.

Tiffany Turner1, Qiujia Shao1, Weiran Wang2, Yudi Wang1, Chenliang Wang1, Ballington Kinlock1, Bindong Liu3.   

Abstract

Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (A3G) is a host restriction factor that impedes HIV-1 replication. Viral integrity is salvaged by HIV-1 virion infectivity factor (Vif), which mediates A3G polyubiquitination and subsequent cellular depletion. Previous studies have implied that A3G polyubiquitination is essential for Vif-induced degradation. However, the contribution of polyubiquitination to the rate of A3G degradation remains unclear. Here, we show that A3G polyubiquitination is essential for degradation. Inhibition of ubiquitin-activating enzyme E1 by PYR-41 or blocking the formation of ubiquitin chains by over-expressing the lysine to arginine mutation of ubiquitin K48 (K48R) inhibited A3G degradation. Our A3G mutagenesis study showed that lysine residues 297, 301, 303, and 334 were not sufficient to render lysine-free A3G sensitive to Vif-mediated degradation. Our data also confirm that Vif could induce ubiquitin chain formation on lysine residues interspersed throughout A3G. Notably, A3G degradation relied on the lysine residues involved in polyubiquitination. Although A3G and the A3G C-terminal mutant interacted with Vif and were modified by ubiquitin chains, the latter remained more resistant to Vif-induced degradation. Furthermore, the A3G C-terminal mutant, but not the N-terminal mutant, maintained potent antiviral activity in the presence of Vif. Taken together, our results suggest that the location of A3G ubiquitin modification is a determinant for Vif-mediated degradation, implying that in addition to polyubiquitination, other factors may play a key role in the rate of A3G degradation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APOBEC3G lysine free mutant; host restriction factor; polyubiquitination; proteasomal degradation; ubiquitin-activating enzyme E1 inhibitor PYR-41

Mesh:

Substances:

Year:  2016        PMID: 27297094      PMCID: PMC5010486          DOI: 10.1016/j.jmb.2016.05.029

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

1.  Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4.

Authors:  P Kaiser; K Flick; C Wittenberg; S I Reed
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

2.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

3.  Ruk is ubiquitinated but not degraded by the proteasome.

Authors:  Frédérique Verdier; Taras Valovka; Alexander Zhyvoloup; Ludmila B Drobot; Vladimir Buchman; Mike Waterfield; Ivan Gout
Journal:  Eur J Biochem       Date:  2002-07

Review 4.  N-terminal ubiquitination: more protein substrates join in.

Authors:  Aaron Ciechanover; Ronen Ben-Saadon
Journal:  Trends Cell Biol       Date:  2004-03       Impact factor: 20.808

5.  Degradation of some polyubiquitinated proteins requires an intrinsic proteasomal binding element in the substrates.

Authors:  Minglian Zhao; Nan-Yan Zhang; Ashley Zurawel; Kirk C Hansen; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.

Authors:  Yudi Wang; Qiujia Shao; Xianghui Yu; Wei Kong; James E K Hildreth; Bindong Liu
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

7.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles.

Authors:  Marc Douaisi; Sylvie Dussart; Marianne Courcoul; Gilles Bessou; Robert Vigne; Etienne Decroly
Journal:  Biochem Biophys Res Commun       Date:  2004-08-27       Impact factor: 3.575

9.  HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation.

Authors:  Junwu Yang; Yi Hong; Wenzong Wang; Weibing Wu; Yayun Chi; Hongliang Zong; Xiangfei Kong; Yuanyan Wei; Xiaojing Yun; Chunming Cheng; Kangli Chen; Jianxin Gu
Journal:  FEBS Lett       Date:  2009-04-18       Impact factor: 4.124

10.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

View more
  5 in total

Review 1.  Ubiquitination and SUMOylation in HIV Infection: Friends and Foes.

Authors:  Marta Colomer-Lluch; Sergio Castro-Gonzalez; Ruth Serra-Moreno
Journal:  Curr Issues Mol Biol       Date:  2019-08-18       Impact factor: 2.081

2.  USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication.

Authors:  Ting Pan; Zheng Song; Liyang Wu; Guangyan Liu; Xiancai Ma; Zhilin Peng; Mo Zhou; Liting Liang; Bingfeng Liu; Jun Liu; Junsong Zhang; Xuanhong Zhang; Ryan Huang; Jiacong Zhao; Yonghong Li; Xuemei Ling; Yuewen Luo; Xiaoping Tang; Weiping Cai; Kai Deng; Linghua Li; Hui Zhang
Journal:  Elife       Date:  2019-08-09       Impact factor: 8.140

Review 3.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

Review 4.  Regulation of Viral Restriction by Post-Translational Modifications.

Authors:  Célia Chamontin; Guillaume Bossis; Sébastien Nisole; Nathalie J Arhel; Ghizlane Maarifi
Journal:  Viruses       Date:  2021-11-01       Impact factor: 5.048

5.  Polymorphisms in Human APOBEC3H Differentially Regulate Ubiquitination and Antiviral Activity.

Authors:  Nicholas M Chesarino; Michael Emerman
Journal:  Viruses       Date:  2020-03-30       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.